Dendrimer based nanoarchitectures in diabetes management: An overview

Vijay Mishra, Nishika Yadav, Gaurav Saraogi, Murtaza M Tambuwala, Namita Giri

Research output: Contribution to journalArticle

Abstract

Diabetes has turned out to be one of the biggest worldwide health and economic burdens, with its expanded predominance and high complexity proportion. The quantity of diabetic patients is expanding enormously around the world. Several reports have demonstrated the sharp increment in the sufferers. Stable and acceptable blood glucose control is fundamental to diminish diabetes-related complications. Consequently, ceaseless endeavors have been made in antidiabetic drugs, treatment strategies, and nanotechnology based products to accomplish better diabetes control. The nanocarriers pertaining hypoglycaemics provide improved diabetes management with minimum risk of associated side effects. Dendrimers have caught an incredible attention in the field of drug delivery and personalized medicines. Dendrimers are three-dimensional well-defined homogenous nanosized structures consisting tree-like branches. The present review highlights the different aspects of dendrimers including fabrication, surface engineering, toxicological profile as well as delivery of antidiabetic drugs for the effective cure of diabetes.
LanguageEnglish
JournalCurrent Pharmaceutical Design
Early online date2019
DOIs
Publication statusE-pub ahead of print - 2019

Fingerprint

Dendrimers
Hypoglycemic Agents
Precision Medicine
Nanotechnology
Diabetes Complications
Toxicology
Blood Glucose
Economics
Pharmaceutical Preparations
Therapeutics

Keywords

  • Diabetes
  • nanomedicine
  • Dendrimers

Cite this

@article{11e1f36493af4b04b286e250ce2bbc93,
title = "Dendrimer based nanoarchitectures in diabetes management: An overview",
abstract = "Diabetes has turned out to be one of the biggest worldwide health and economic burdens, with its expanded predominance and high complexity proportion. The quantity of diabetic patients is expanding enormously around the world. Several reports have demonstrated the sharp increment in the sufferers. Stable and acceptable blood glucose control is fundamental to diminish diabetes-related complications. Consequently, ceaseless endeavors have been made in antidiabetic drugs, treatment strategies, and nanotechnology based products to accomplish better diabetes control. The nanocarriers pertaining hypoglycaemics provide improved diabetes management with minimum risk of associated side effects. Dendrimers have caught an incredible attention in the field of drug delivery and personalized medicines. Dendrimers are three-dimensional well-defined homogenous nanosized structures consisting tree-like branches. The present review highlights the different aspects of dendrimers including fabrication, surface engineering, toxicological profile as well as delivery of antidiabetic drugs for the effective cure of diabetes.",
keywords = "Diabetes, nanomedicine, Dendrimers",
author = "Vijay Mishra and Nishika Yadav and Gaurav Saraogi and Tambuwala, {Murtaza M} and Namita Giri",
year = "2019",
doi = "10.2174/1381612825666190716125332",
language = "English",
journal = "Current Pharmaceutical Design",
issn = "1381-6128",

}

Dendrimer based nanoarchitectures in diabetes management: An overview. / Mishra, Vijay; Yadav, Nishika ; Saraogi, Gaurav; Tambuwala, Murtaza M; Giri, Namita.

In: Current Pharmaceutical Design, 2019.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Dendrimer based nanoarchitectures in diabetes management: An overview

AU - Mishra, Vijay

AU - Yadav, Nishika

AU - Saraogi, Gaurav

AU - Tambuwala, Murtaza M

AU - Giri, Namita

PY - 2019

Y1 - 2019

N2 - Diabetes has turned out to be one of the biggest worldwide health and economic burdens, with its expanded predominance and high complexity proportion. The quantity of diabetic patients is expanding enormously around the world. Several reports have demonstrated the sharp increment in the sufferers. Stable and acceptable blood glucose control is fundamental to diminish diabetes-related complications. Consequently, ceaseless endeavors have been made in antidiabetic drugs, treatment strategies, and nanotechnology based products to accomplish better diabetes control. The nanocarriers pertaining hypoglycaemics provide improved diabetes management with minimum risk of associated side effects. Dendrimers have caught an incredible attention in the field of drug delivery and personalized medicines. Dendrimers are three-dimensional well-defined homogenous nanosized structures consisting tree-like branches. The present review highlights the different aspects of dendrimers including fabrication, surface engineering, toxicological profile as well as delivery of antidiabetic drugs for the effective cure of diabetes.

AB - Diabetes has turned out to be one of the biggest worldwide health and economic burdens, with its expanded predominance and high complexity proportion. The quantity of diabetic patients is expanding enormously around the world. Several reports have demonstrated the sharp increment in the sufferers. Stable and acceptable blood glucose control is fundamental to diminish diabetes-related complications. Consequently, ceaseless endeavors have been made in antidiabetic drugs, treatment strategies, and nanotechnology based products to accomplish better diabetes control. The nanocarriers pertaining hypoglycaemics provide improved diabetes management with minimum risk of associated side effects. Dendrimers have caught an incredible attention in the field of drug delivery and personalized medicines. Dendrimers are three-dimensional well-defined homogenous nanosized structures consisting tree-like branches. The present review highlights the different aspects of dendrimers including fabrication, surface engineering, toxicological profile as well as delivery of antidiabetic drugs for the effective cure of diabetes.

KW - Diabetes

KW - nanomedicine

KW - Dendrimers

U2 - 10.2174/1381612825666190716125332

DO - 10.2174/1381612825666190716125332

M3 - Article

JO - Current Pharmaceutical Design

T2 - Current Pharmaceutical Design

JF - Current Pharmaceutical Design

SN - 1381-6128

ER -